← Leaderboards
Stephen Michael Kaminsky
Weill Medical Coll Of Cornell Univ
$4,824,238
Attributed
$9,572,526
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2006–24$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,572,526 · 5
By mechanism
R33$5,884,638 · 1
U01$1,554,219 · 1
R01$1,089,888 · 1
P01$623,403 · 1
R61$420,378 · 1
Top collaborators
- Ronald G Crystal4 shared
- Jonathan W. Weinsaft4 shared
- Stefan Worgall3 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Stefan Worgall$14,468,848
- Gary M Brittenham$18,110,961
- Helena Knotkova$3,717,431
- Fei Wang$8,043,905
- Jonathan W. Weinsaft$12,053,026
Others in their field
Top investigators on “Vector”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- David Heimbrook · Leidos Biomedical Research, Inc.$141,066,079
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,296,230
- Philip Goode · New Jersey Institute Of Technology$73,697,028
Research focus
VectorProductionGenesDoseToxicologyQuality ControlSerumComplementary DnaReportingProceduresClinical TrialsMouse ModelDependovirusSerotypingCapsidGenomeGeneticBaseLinkManufacturing ProcessClinical ResearchNonhuman PrimateProtocols DocumentationGene Therapy
Grant awards (13)
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia$1,380,330
R33 · FY2024 · HL
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia$2,104,654
R33 · FY2023 · HL
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia$2,399,654
R33 · FY2022 · HL
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia$420,378
R61 · FY2020 · HL
Vector Project - Gene Therapy for Metachromatic Leukodystrophy$872,818
U01 · FY2014 · NS · contact PI
Adenovirus-based Nanoparticle Vaccines$350,548
R01 · FY2013 · DA · contact PI
Adenovirus-based Nanoparticle Vaccines$365,155
R01 · FY2012 · DA · contact PI
Vector Project - Gene Therapy for Metachromatic Leukodystrophy$339,504
U01 · FY2012 · NS · contact PI
Adenovirus-based Nanoparticle Vaccines$374,185
R01 · FY2011 · DA · contact PI
Vector Project - Gene Therapy for Metachromatic Leukodystrophy$341,897
U01 · FY2011 · NS · contact PI
CORE-- VECTOR CORE$233,228
P01 · FY2008 · HL · contact PI
CORE-- VECTOR CORE$231,040
P01 · FY2007 · HL · contact PI
CORE-- VECTOR CORE$159,135
P01 · FY2006 · HL · contact PI